Trial Profile
Randomized controlled trial comparing the effect of GnRH [gonadotropin releasing hormone] agonist [triptorelin] and antagonist [ganirelix] ovarian stimulation protocols in PCOS [polycystic ovarian syndrome] patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Ganirelix (Primary) ; Triptorelin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 01 Mar 2010 Results published in Human Reproduction.
- 03 Feb 2007 New trial record.